134 results
Page 6 of 7
424B5
zif33hmwgv
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
lqx4votyusw9zpeesb9e
4 Mar 15
Prospectus supplement for primary offering
12:00am
8-K
EX-99.3
tzodk7jq4j
4 Mar 15
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
12:00am
424B3
uz82uxwd6mnf
16 May 14
Prospectus supplement
12:00am
424B3
ucougggd6
4 Apr 14
Prospectus supplement
12:00am
424B1
tc6rh98wpuqf
31 Jan 14
Prospectus with pricing info
12:00am
8-K
EX-14.1
d985u0sdnh
7 Jan 14
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
424B3
f8dbx8
19 Dec 13
Prospectus supplement
12:00am
8-K
EX-99.1
zjc0lq8i05tbg k7wx
9 Dec 13
Intra-Cellular Therapies Announces Positive Topline Phase II Clinical Results of ITI-007 for the Treatment of Schizophrenia
12:00am
8-K/A
0eudb 33i6n4
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-10.2
k8egayv mvultf4di4
31 Oct 13
Entry into a Material Definitive Agreement
12:00am